Skip to main content
Sirolimus-tacrolimus combination immunosuppression.
Lancet (2000)
  • Vivian C. McAlister, Dalhousie University
  • Zu-hua Gao, Dalhousie University
  • Kevork Peltekian, Dalhousie University
  • Javier Domingues, Dalhousie University
  • Kamran Mahalati, Dalhousie University
  • Allan S MacDonald, Dalhousie University

A series of 32 recipients of liver, kidney, or pancreas transplants who were treated with sirolimus and low-dose tacrolimus experienced a low rate of rejection and excellent graft function without drug-related toxic effects.

  • transplantation; liver transplantation; pancreas transplantation; tacrolimus; sirolimus
Publication Date
Citation Information
Vivian C. McAlister, Zu-hua Gao, Kevork Peltekian, Javier Domingues, et al.. "Sirolimus-tacrolimus combination immunosuppression." Lancet Vol. 355 Iss. 9201 (2000)
Available at: